Today's Pre-Market Stock Movers: PEP, MRNA, BGNE, CCJ and More
Gapping up
In reaction to earnings/guidance:
Other news:
• $El Pollo Loco(LOCO.US$ +12.7% (declares $1.50/sh special div; also authorizes new $20 mln share repurchase program)
• $KnowBe4(KNBE.US$ +11.4% (KnowBe4 is close to a deal to be acquired by Vista Equity Partners according to WSJ)
• $Autolus Therapeutics(AUTL.US$ +9.1% (announces that Moderna has exercised its option to license Autolus’ proprietary binders against an undisclosed immuno-oncology target for the development and commercialization of mRNA therapeutics)
• $Rocket Pharmaceuticals(RCKT.US$ +4.5% (Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy)
• $Sangamo Therapeutics(SGMO.US$ +4.2% (Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Nine Patients)
• $Moderna(MRNA.US$+3% (Moderna & Merck (MRK) announce exercise of option by Merck for joint development and commercialization of investigational personalized cancer vaccine)
• $ATAI Life Sciences(ATAI.US$ +3% (positive initial results for phase 1 trial of KUR-101 an oral formulation of mitragynine for OUD)
• $BeiGene(BGNE.US$ +2.3% (announces positive topline results from final progression-free survival analysis of BRUKINSA (zanubrutinib) Compared to IMBRUVICA (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia Trial)
Gapping down
In reaction to earnings/guidance:
Other news:
• $Cameco(CCJ.US$ -12.4% (CCJ and BEP form partnership to acquire Westinghouse Electric; also announces $650M bought deal offering; also provides Q3 operating update)
• $Eagle Pharmaceuticals(EGRX.US$ -1.3% (files $200 mln mixed securities shelf offering; also submitted an investigational new drug application to the FDA for CAL02 for the treatment of severe community-acquired bacterial pneumonia)
Moomoo is an app offered by Moomoo Technologies Inc. that provides information about investments. Moomoo Technologies is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of Moomoo Technologies, its affiliates, or any employees of Moomoo Technologies or its affiliates. You are advised to consult a qualified financial or tax advisor for your personal financial planning and tax situations. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.
Comment
Sign in to post a comment